Evidence map›Paper›PMID 37529926›Full record

ArticleThe Journal of general virology2023

Inhibition of salt inducible kinases reduces rhythmic HIV-1 replication and reactivation from latency.

Helene Borrmann, Dini Ismed, Anna E Kliszczak, Persephone Borrow, Sridhar Vasudevan, Aarti Jagannath, Xiaodong Zhuang, Jane A McKeating

Open access · hybridAbstract read
In one paragraph

Article in The Journal of general virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Helene BorrmannNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Dini IsmedNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Anna E KliszczakNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Persephone BorrowNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Sridhar VasudevanDepartment of Pharmacology, University of Oxford, Oxford, UK.
Aarti JagannathSleep and Circadian Neuroscience Institute (SCNi), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Xiaodong ZhuangNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Jane A McKeatingNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
University of Oxford · GBChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Collaboratory of AIDS Researchers for Eradication (CARE)UM1AI164567 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2021 to 2026
$31.6M
Medical Research Council MR/R022011/1NIAID NIH HHS UM1 AI164567Wellcome Trust 108869/Z/15/ZWellcome Trust 200838/Z/16/Z
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) causes a major burden on global health, and eradication of latent virus infection is one of the biggest challenges in the field. The circadian clock is an endogenous timing system that oscillates with a ~24 h period regulating multiple physiological processes and cellular functions, and we recently reported that the cell intrinsic clock regulates rhythmic HIV-1 replication. Salt inducible kinases (SIK) contribute to circadian regulatory networks, however, there is limited evidence for SIKs regulating HIV-1 infection. Here, we show that pharmacological inhibition of SIKs perturbed the cellular clock and reduced rhythmic HIV-1 replication in circadian synchronised cells. Further, SIK inhibitors or genetic silencing of

Indexed as

HIV-1HIV InfectionsHumansVirus LatencyVirus Replicationcircadian rhythmsHIV-1host-pathogen interactionssalt inducible kinases

Identifiers

PMID37529926
PMCPMC10721046
OpenAlexW4385477311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.